Company Name: Mesoblast Limited
Mesoblast Limited is a regenerative medicine company. The company has developed a broad portfolio of late-stage product candidates using its proprietary mesenchymal lineage adult stem cell (MLC)-based platform in several therapeutic areas including:
- Cardiac diseases
- Immune-mediated and inflammatory disorders
- Oncology and hematology conditions
- Spine orthopedic disorders
Ticker Symbol: MESO (NASDAQ)
Ticker Symbol: MSB (ASX)
Company Website: www.mesoblast.com
Social Media:
Headquarters: Melbourne, Australia